CommercialBilling CodesHigh impact
New Claims Editing Rules To Be Implemented in December 2026
BCBS Oklahoma·OK · Ophthalmology, Endocrinology, Rheumatology +1 more·Reimbursement
Effective date
Dec 1, 2026
We identified it
Aug 22, 2026
Summary
Effective December 1, 2026, Blue Cross Blue Shield of Oklahoma will implement new claims editing rules in their Lyric software that enforce specific drug usage limits and require proper wastage modifier application for six HCPCS codes. Claims that fail these edits will receive rejection reason codes beginning with 'G'. Billing teams must update their claim submission processes to ensure compliance with new quantity limits for injectable drugs and proper documentation of drug wastage.
Action Required
By November 15, 2026: Billing team must implement the following changes in billing software and workflows: (1) Configure J0897 (Denosumab) to enforce a maximum of 60 units per 6 months for osteoporosis diagnoses; (2) Configure J0178 (Aflibercept) to enforce a maximum of 4 units per 4 weeks; (3) Configure J2778 (Ranibizumab) to enforce a maximum of 5 units per 4 weeks; (4) Configure J2502 (Pasireotide) to enforce a maximum of 60 units per 4 weeks for acromegaly diagnoses; (5) Configure Q5128 (Ranibizumab-eqrn) to enforce a maximum of 10 units per 4 weeks for wet AMD, RVO, and myopic CNV diagnoses; (6) Configure system to flag any single-use vial or package drug codes that are missing drug wastage modifiers (JW or JZ) for review before submission. Providers must review their current prescribing patterns for these drugs and update documentation to support medical necessity. Use Clear Claim Connection tool to test coding combinations before December 1. Claims submitted with quantity overages or missing wastage modifiers will receive edit rejections beginning with 'G' and will not be paid. This applies to professional and outpatient facility claims only.